B.AkourA.et al
Wang, L., Xu, R., Kaelber, D
Market context: where Cora and Eden sit in the 2026 compounded GLP-1 market Four numbers anchor the head-to-head comparison between Cora Health and Eden in 2026: 41.9% US adult obesity prevalence
The implication for cost comparison: when evaluating Cora Health versus Eden, patients can use the published monthly prices at face value without modeling dose-based escalation
Ashwagandha is possibly effective for insomnia, anxiety, and stress
These materials are not classified as drugs, pharmaceuticals, dietary supplements, or medical products